HOME >> BIOLOGY >> NEWS
Surprising study reveals how cancer-causing protein activates

PROVIDENCE, R.I. -- Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.

The team of cell biologists has discovered a new chemical modification that activates STAT3. This so-called signaling protein is important for embryonic growth and development, helping cells grow, duplicate and migrate. In adulthood, STAT3 presumably falls dormant, but its unexpected and continuous activation causes breast and prostate cells to develop and move through the body.

Eugene Chin, M.D., a Rhode Island Hospital researcher and assistant professor (research) of surgery at Brown Medical School, said experts suspect that environmental factors, such as a diet rich in animal fat and hormones, may activate STAT3.

How the protein is turned on inside cells has been the subject of fiercely competitive research during the last decade. One known trigger is phosphorylation, which modifies some of the tyro-sine and serine amino acids that make up the STAT3 protein. Chin and his team found a second trigger: acetylation, another chemical process that modifies amino acids, such as lysine. Chin said this finding might explain why drugs that only block STAT3 phosphorylation cannot completely stop cancer cells from growing and invading other parts of the body.

"Both tyrosine phosphorylation and lysine acetylation modifications are important events for STAT3 to stimulate cancer cell growth and metastasis," Chin said. "That's why the finding is so exciting. Now that we know more about STAT3 activation, we can create better drugs."

Their findings are published in the current issue of Science.

Paul Yuan, a post-doctoral fellow in Chin's Rhode Island Hospital lab and the lead author of the paper, painstakingly mutated 47 lysine amino acids and tested each one in cultured
'"/>

Contact: Wendy Lawton
Wendy_Lawton@brown.edu
401-863-1862
Brown University
13-Jan-2005


Page: 1 2

Related biology news :

1. Surprising new species of light-harvesting bacterium discovered in Yellowstone
2. Surprising origin of cells internal highways
3. Surprising airbag hazards among research findings at hearing safety conference
4. Surprising symbiosis: Glassy-winged sharpshooter eats with friends
5. Surprising genetic differences id-ed in southern house mosquito
6. Surprising killer of southeastern salt marshes: Common sea snails
7. Growing lymph vessels with macrophages? Surprisingly, yes!
8. Surprisingly complex behaviors appear to be hard-wired in the primate brain
9. New study warns limited carbon market puts 20 percent of tropical forest at risk
10. Clones on task serve greater good, evolutionary study shows
11. Pollution causes 40 percent of deaths worldwide, study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
(Date:1/27/2020)... ... ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), join Gary ... Castle, Global Account Manager Medical Device at PRISYM ID for an informative ... deadlines, best practices in creating and submitting product data and best practices in preparing ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome research ... announced that the company will debut a novel new DNA isolation kit at the ... product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... antibody products and services, today announced the launch of its VivopureX™ recombinant mouse ... antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody has ...
(Date:12/31/2019)... (PRWEB) , ... December 31, 2019 , ... ... in expanding its pharmaceutical product development lab in Maryland. Emphasis will ... increased size and expanded capabilities, Vici Health Sciences will be well positioned to ...
Breaking Biology Technology:
Cached News: